Athanor Capital, LP Cytom X Therapeutics, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$6.6 - $9.0 $178,582 - $243,522	-27,058 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $4,089 - $4,992	632 Added 2.39%	27,058 $177,000
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $132,879 - $179,134	-20,287 Reduced 43.43%	26,426 $176,000
Q2 2020 Aug 13, 2020	BUY	$7.4 - $14.64 $345,676 - $683,878	46,713 New	46,713 $389,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $67.3M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.